Status:
RECRUITING
Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease
Lead Sponsor:
Betul Uner
Conditions:
Graves Disease (Basedow's Disease)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this single-blind, randomized, experimental study was to investigate the effect of Rubus sanctus root extract, which has antioxidant properties, added to the routine diet of patients with G...
Detailed Description
Humanity has fought many battles for survival. One of the most important of these battles is the fight against disease. The imbalance between free radicals and antioxidants in the body leads to oxidat...
Eligibility Criteria
Inclusion
- Patients with a new diagnosis of Graves' disease or those with a relapse of Graves' disease
- Patients aged 18-65
- A score of 80 or higher on the Health Eating Index (HEI)
Exclusion
- Having received treatment for the disease within the last 6 months
- Having another chronic and/or autoimmune disease
- Being pregnant or lactating
Key Trial Info
Start Date :
December 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT07164079
Start Date
December 12 2024
End Date
June 30 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muğla Sıtkı Koçman University/Muğla Training and Research Hospital Endocrine and Metabolic Diseases Polyclinic
Muğla, Mentese, Turkey (Türkiye), 48000